Работы, на которые ссылается эта работа

Работ: 378

Работа: Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Обзорная статья2011Цитирований: 18
ABI
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang, Pengfei Shi, Gaichao Zhao +8
Обзорная статья2020Цитирований: 5
ABI
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim, Kun‐Liang Guan
Обзорная статья2015Цитирований: 4
ABI
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Обзорная статья2018Цитирований: 4
ABI
Targeting non-coding RNAs to overcome cancer therapy resistance
Baoqing Chen, Mihnea P. Dragomir, Yang Chen +3
Обзорная статья2022Цитирований: 4
ABI
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Yujie Li, Qin Jiang, Guo-Fan Cao +2
Обзорная статья2015Цитирований: 3
ABI
The Role of mTOR Signaling as a Therapeutic Target in Cancer
N. V. Popova, Manfred Jücker
Обзорная статья2021Цитирований: 3
ABI
Без названия
ДругоеЦитирований: 3
ABI
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells
M.-s. Jung, Jin Kyung Rho, Y-M Kim +7
Статья2012Цитирований: 2
ABI
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin, Marco Colombi, Christoph Moroni +1
Обзорная статья2011Цитирований: 2
ABI
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
Anna V. Tinker, Susan Ellard, Stephen Welch +7
Статья2013Цитирований: 2
ABI
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim +5
Статья2004Цитирований: 2
ABI
mTOR Signaling in Growth Control and Disease
Mathieu Laplante, David M. Sabatini
Обзорная статья2012Цитирований: 2
ABI
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by <i>Nanoparticle Albumin-Bound</i> –Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
Diana Cirstea, Teru Hideshima, Scott J. Rodig +15
Статья2010Цитирований: 2
ABI
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton, David M. Sabatini
Обзорная статья2017Цитирований: 2
ABI
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer
Pedro C. Barata, Matthew M. Cooney, Prateek Mendiratta +3
Статья2018Цитирований: 2
ABI
Autophagy, cancer stem cells and drug resistance
Alexandra G. Smith, Kay F. Macleod
Обзорная статья2018Цитирований: 2
ABI
Overexpression of long noncoding RNA GAS5 suppresses tumorigenesis and development of gastric cancer by sponging miR-106a-5p through the Akt/mToR pathway
Shuaijun Dong, Xiefu Zhang, Dechun Liu
Препринт2019Цитирований: 2
ABI
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang, Ji Nie, Xuelei Ma +3
Обзорная статья2019Цитирований: 2
ABI
The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary
S Sneha, Rohit P. Nagare, Chirukandath Sidhanth +6
Статья2020Цитирований: 2
ABI
The double-edged sword of H19 lncRNA: Insights into cancer therapy
Yun Wei Shermane Lim, Xiaoqiang Xiang, Manoj Garg +4
Обзорная статья2020Цитирований: 2
ABI
Targeting tumor-associated macrophages to synergize tumor immunotherapy
Xiaonan Xiang, Jianguo Wang, Di Lu +1
Обзорная статья2021Цитирований: 2
ABI
Targeting PI3K/Akt signal transduction for cancer therapy
Yan He, Miao Sun, Guo Geng Zhang +4
Обзорная статья2021Цитирований: 2
ABI
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
Sahar Mafi, Behzad Mansoori, Shahram Taeb +4
Обзорная статья2022Цитирований: 2
ABI
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
Mengshu You, Zhuolin Xie, Nan Zhang +6
Обзорная статья2023Цитирований: 2
ABI